Revance

Financing March 21, 2022

From the firm's own website

Athyrium Capital Managementfirm provided financing to Revance on Mar 21, 2022.
Websiteitem page
The website reads: “Revance Closes on $300 Million Note Purchase Agreement with Athyrium Capital Management”.
Websiteitem page
The firm's website puts the debt at $300M.
Website
Athyrium Capital Managementfirm also worked on Corstasis Therapeuticsdeal, on Apr 2, 2026.
Websiteitem page

At a glance

Who was on each side

SellerNot named in the sources

The companyRevanceMar 21, 2022

BuyerAthyrium Capital Management

Each party is named in the sources beside the statement

Parties

Party	Role	Source
Athyrium Capital Management	Buyer	Websiteitem page

Value

Kind	Amount	Basis	Source
Debt	$300M	note (stated on the firm's site)	Website

More deals

first 2 of 5

Date	Deal	Firms	Source
Apr 2, 2026	Corstasis Therapeutics · Acquisition	Athyrium Capital Management	Websiteitem page
Apr 2, 2026	Esperion Therapeutics · Financing	Athyrium Capital Management	Websiteitem page

3 more deals

Deals with Athyrium Capital Management.

Sign up free to see all 5.

On file

Date as stated: March 21, 2022Websiteitem page

Browse the database